The findings revealed elevated MTFR2 expression in endometrial cancer, which subsequently facilitated tumor cell proliferation via the activation of the phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI3K)-protein kinase B (Akt) signaling pathway. Here, MTFR2 is linked to endometrial cancer.